Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 334

1.

Surgery and staging of pancreatic neuroendocrine tumors: a 14-year experience.

Ito H, Abramson M, Ito K, Swanson E, Cho N, Ruan DT, Swanson RS, Whang EE.

J Gastrointest Surg. 2010 May;14(5):891-8. doi: 10.1007/s11605-010-1173-3. Epub 2010 Mar 12.

PMID:
20224984
[PubMed - indexed for MEDLINE]
2.

Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors.

Bilimoria KY, Bentrem DJ, Merkow RP, Tomlinson JS, Stewart AK, Ko CY, Talamonti MS.

J Am Coll Surg. 2007 Oct;205(4):558-63. Epub 2007 Aug 3.

PMID:
17903729
[PubMed - indexed for MEDLINE]
3.

The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.

Riediger H, Keck T, Wellner U, zur Hausen A, Adam U, Hopt UT, Makowiec F.

J Gastrointest Surg. 2009 Jul;13(7):1337-44. doi: 10.1007/s11605-009-0919-2. Epub 2009 May 6.

PMID:
19418101
[PubMed - indexed for MEDLINE]
4.

Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients.

Scarpa A, Mantovani W, Capelli P, Beghelli S, Boninsegna L, Bettini R, Panzuto F, Pederzoli P, delle Fave G, Falconi M.

Mod Pathol. 2010 Jun;23(6):824-33. doi: 10.1038/modpathol.2010.58. Epub 2010 Mar 19.

PMID:
20305616
[PubMed - indexed for MEDLINE]
Free Article
5.

Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: an analysis of the AJCC and ENETS staging classifications.

Strosberg JR, Cheema A, Weber JM, Ghayouri M, Han G, Hodul PJ, Kvols LK.

Ann Surg. 2012 Aug;256(2):321-5. doi: 10.1097/SLA.0b013e31824e6108.

PMID:
22415420
[PubMed - indexed for MEDLINE]
6.

Nonfunctioning neuroendocrine pancreatic tumors: our experience and management.

Nomura N, Fujii T, Kanazumi N, Takeda S, Nomoto S, Kasuya H, Sugimoto H, Yamada S, Nakao A.

J Hepatobiliary Pancreat Surg. 2009;16(5):639-47. doi: 10.1007/s00534-009-0099-1. Epub 2009 Apr 14.

PMID:
19365596
[PubMed - indexed for MEDLINE]
7.

Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.

Norton JA, Kivlen M, Li M, Schneider D, Chuter T, Jensen RT.

Arch Surg. 2003 Aug;138(8):859-66.

PMID:
12912744
[PubMed - indexed for MEDLINE]
8.

Prognostic factors and survival in patients with neuroendocrine tumors of the pancreas.

Wang DS, Zhang DS, Qiu MZ, Wang ZQ, Luo HY, Wang FH, Li YH, Xu RH.

Tumour Biol. 2011 Aug;32(4):697-705. doi: 10.1007/s13277-011-0170-9. Epub 2011 Apr 9.

PMID:
21479734
[PubMed - indexed for MEDLINE]
9.

Surgical experience with nonfunctioning neuroendocrine tumors of the pancreas.

Matthews BD, Heniford BT, Reardon PR, Brunicardi FC, Greene FL.

Am Surg. 2000 Dec;66(12):1116-22; discussion 1122-3.

PMID:
11149582
[PubMed - indexed for MEDLINE]
10.

The outcomes after surgical resection in pancreatic endocrine tumors: an institutional experience.

You DD, Lee HG, Paik KY, Heo JS, Choi SH, Choi DW.

Eur J Surg Oncol. 2009 Jul;35(7):728-33. doi: 10.1016/j.ejso.2009.01.006. Epub 2009 Feb 1.

PMID:
19188040
[PubMed - indexed for MEDLINE]
11.

Multidisciplinary treatment strategy for advanced pancreatic neuroendocrine tumors- a single center experience.

Tsuchikawa T, Hirano S, Tanaka E, Kato K, Matsumoto J, Sichinohe T.

Hepatogastroenterology. 2012 Nov-Dec;59(120):2623-6.

PMID:
22497945
[PubMed - indexed for MEDLINE]
12.

Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas.

Fischer L, Kleeff J, Esposito I, Hinz U, Zimmermann A, Friess H, Büchler MW.

Br J Surg. 2008 May;95(5):627-35. doi: 10.1002/bjs.6051.

PMID:
18306152
[PubMed - indexed for MEDLINE]
13.

Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients.

Bilimoria KY, Talamonti MS, Tomlinson JS, Stewart AK, Winchester DP, Ko CY, Bentrem DJ.

Ann Surg. 2008 Mar;247(3):490-500. doi: 10.1097/SLA.0b013e31815b9cae.

PMID:
18376195
[PubMed - indexed for MEDLINE]
14.

Pathologic staging of renal cell carcinoma: significance of tumor classification with the 1997 TNM staging system.

Gettman MT, Blute ML, Spotts B, Bryant SC, Zincke H.

Cancer. 2001 Jan 15;91(2):354-61.

PMID:
11180082
[PubMed - indexed for MEDLINE]
15.

Determining prognosis in patients with pancreatic endocrine neoplasms: can the WHO classification system be simplified?

Ferrone CR, Tang LH, Tomlinson J, Gonen M, Hochwald SN, Brennan MF, Klimstra DS, Allen PJ.

J Clin Oncol. 2007 Dec 10;25(35):5609-15.

PMID:
18065733
[PubMed - indexed for MEDLINE]
16.

[Prediction of prognosis of patients with pancreatic adenocarcinoma with curative intent resection by means of histologic grade and pathologic N stage].

Soriano-Izquierdo A, Adet AC, Gallego R, Miquel R, Castells A, Pellisé M, Nadal C, López-Boado MA, Piqué JM, Gascón P, Conill C, Bombí A, Fernández-Cruz L, Maurel J, Navarro S.

Med Clin (Barc). 2009 Feb 14;132(5):163-71. doi: 10.1016/j.medcli.2008.07.012. Epub 2009 Feb 7. Spanish.

PMID:
19211081
[PubMed - indexed for MEDLINE]
17.

Is the new classification of neuroendocrine pancreatic tumors of clinical help?

Schindl M, Kaczirek K, Kaserer K, Niederle B.

World J Surg. 2000 Nov;24(11):1312-8.

PMID:
11038199
[PubMed - indexed for MEDLINE]
18.

TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study.

Rindi G, Falconi M, Klersy C, Albarello L, Boninsegna L, Buchler MW, Capella C, Caplin M, Couvelard A, Doglioni C, Delle Fave G, Fischer L, Fusai G, de Herder WW, Jann H, Komminoth P, de Krijger RR, La Rosa S, Luong TV, Pape U, Perren A, Ruszniewski P, Scarpa A, Schmitt A, Solcia E, Wiedenmann B.

J Natl Cancer Inst. 2012 May 16;104(10):764-77. doi: 10.1093/jnci/djs208. Epub 2012 Apr 23.

PMID:
22525418
[PubMed - indexed for MEDLINE]
Free Article
19.

[Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].

Ridwelski K, Meyer F, Schmidt U, Lippert H.

Zentralbl Chir. 2005 Aug;130(4):353-61. German.

PMID:
16103961
[PubMed - indexed for MEDLINE]
20.

Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.

Le QT, Fu KK, Kaplan M, Terris DJ, Fee WE, Goffinet DR.

Cancer. 1999 Nov 1;86(9):1700-11.

PMID:
10547542
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk